Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluating the impact of pre‐diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone‐related cancers: Surveillance, Epidemiology, and End Results‐Medicare 2007–2015

Andrology(2024)10.1111/andr.13616Source: DataRank Database

Evaluating the impact of pre‐diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone‐related cancers: Surveillance, Epidemiology, and End Results‐Medicare 2007–2015 is a research paper published in Andrology (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.00)OA: bronzeTopics (35)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Omer Abdelgadir ORCID,Efstathia Polychronopoulou ORCID,Konstantinos K. Tsilidis ORCID,Laith Alzweri ORCID,Alejandro Villasante‐Tezanos ORCID

Live enrichment

PubMed:38421134 PMC:PMC11358361 OpenAlex:https://openalex.org/W4392295640

National Institute on Aging

Grant: P30 AG059301

National Institute on Aging

Grant: T32 AG000270

Cancer Prevention and Research Institute of Texas

Grant: RP210130

NCI NIH HHS

Grant: HHSN261201800009I

NCI NIH HHS

Grant: HHSN261201800015C

NCI NIH HHS

Grant: HHSN261201800032I

NCI NIH HHS

Grant: HHSN261201800009C

NCI NIH HHS

Grant: HHSN261201800015I

NCI NIH HHS

Grant: HHSN261201800032C

NCCDPHP CDC HHS

Grant: NU58DP006344

National Institutes of Health

FWCI

0.00

Citation Percentile

0.0%

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/andr.13616

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/andr.13616

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/andr.13616

journalhttp://dx.doi.org/10.1111/andr.13616

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38421134

Fields of Study

Cancer, Lipids, and MetabolismProstate Cancer Treatment and ResearchMale Breast Health Studies

MeSH Terms

AgedAged, 80 and overMedicareHumansMaleProstatic NeoplasmsTestosteroneUnited StatesColorectal NeoplasmsSEER ProgramBreast Neoplasms, MaleHydroxymethylglutaryl-CoA Reductase InhibitorsHormone Replacement Therapy

Keywords

MedicineProstate cancerHazard ratioOncologyInternal medicineProportional hazards modelHormone replacement therapy (female-to-male)CancerBreast cancerEpidemiologyHormone therapyColorectal cancerTestosterone (patch)GynecologyConfidence intervalTestosteroneMale breast cancerSurvival Outcomestatins

Sustainable Development Goals

SDG 0: Good health and well-being